1  Consideration should be given to developing additional safeguards against ICU errors, particularly d

2  enhancing the safety of these products, but additional safeguards could be implemented, and unlike d

3 ocess; procedures used operationally include additional safeguards designed to minimize errors.

4 ure or prohibition of conflicts of interest, additional safeguards for sensitive medical conditions,

5 e other major U.S. groups have also proposed additional safeguards for this population, and existing

6 s circumvented, kappa editing and anergy are additional safeguards preventing 2F5 V(H)/V(L) expressio

7 ith geminin, whereas noncancer cells contain additional safeguards that prevent DNA re-replication.

8 before sprouting and reinforces the need for additional safeguards to protect the public.